Lumos Pharma Inc. buy DomRuinart
Start price
11.01.21
/
50%
€18.00
Target price
11.01.22
€25.00
Performance (%)
-17.22%
End price
25.01.21
€14.90
Summary
This prediction ended on 25.01.21 with a price of €14.90. The price of Lumos Pharma Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.22%. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Lumos Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 0,30 % | 4,70 % | 4,54 % | 51,55 % |
| iShares Nasdaq 100 | 0,43 % | 12,26 % | 31,98 % | 98,29 % |
| iShares Nikkei 225® | 1,63 % | 12,62 % | 43,26 % | 69,87 % |
| iShares S&P 500 | 0,57 % | 7,79 % | 23,48 % | 69,79 % |
According to DomRuinart what are the pros and cons of Lumos Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread NewLink Genetics Corp diskutieren
Buy mit Kursziel 25,0